Connor, Clark & Lunn Investment Management Ltd. Merrimack Pharmaceuticals Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$12.02 - $13.07 $173,148 - $188,273	14,405 New	14,405 $177,000
Q3 2019 Nov 13, 2019	SELL	$4.16 - $6.05 $202,791 - $294,925	-48,748 Reduced 31.28%	107,098 $481,000
Q2 2019 Aug 07, 2019	SELL	$4.39 - $5.66 $26,023 - $33,552	-5,928 Reduced 3.66%	155,846 $943,000
Q1 2019 May 08, 2019	SELL	$3.19 - $5.73 $23,287 - $41,829	-7,300 Reduced 4.32%	161,774 $1.12 Million
Q4 2018 Feb 12, 2019	SELL	$2.95 - $4.15 $7,375 - $10,375	-2,500 Reduced 1.46%	169,074 $653,000
Q3 2018 Nov 13, 2018	SELL	$3.91 - $4.66 $12,512 - $14,912	-3,200 Reduced 1.83%	171,574 $914,000
Q2 2018 Aug 02, 2018	BUY	$3.86 - $7.61 $121,624 - $239,783	31,509 Added 21.99%	174,774 $858,000
Q1 2018 May 14, 2018	BUY	$6.24 - $9.15 $340,860 - $499,818	54,625 Added 61.63%	143,265 $1.15 Million
Q4 2017 Feb 09, 2018	BUY	$7.99 - $11.87 $422,295 - $627,365	52,853 Added 147.69%	88,640 $909,000
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $326,735 - $419,423	35,787	35,787 $520,000

Others Institutions Holding MACK

# of Institutions

Shares Held

349

Call Options Held

Put Options Held

View Full List

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account